Tonix Pharmaceuticals Holding Corp. Forecast, price target & analysts
Tonix Pharmaceuticals Holding Corp. Target price 2026 - Analyst rating & recommendation
Tonix Pharmaceuticals Holding Corp. Classifications & Recommendation
Tonix Pharmaceuticals Holding Corp. Price Target
| Target Price | $34.68 |
| Price | $8.91 |
| Potential |
289.23%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Tonix Pharmaceuticals Holding Corp. 2027 .
The average Tonix Pharmaceuticals Holding Corp. target price is $34.68.
This is
289.23%
register free of charge
$68.25
665.99%
register free of charge
$22.22
149.38%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend Tonix Pharmaceuticals Holding Corp. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Tonix Pharmaceuticals Holding Corp. stock has an average upside potential 2027 of
289.23%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 13.11 | 56.10 |
| 29.93% | 327.94% | |
| Net Margin | -946.00% | -310.34% |
| 26.60% | 67.19% |
6 Analysts have issued a sales forecast Tonix Pharmaceuticals Holding Corp. 2026 . The average Tonix Pharmaceuticals Holding Corp. sales estimate is
This results in the following potential growth metrics:
7 Tonix Pharmaceuticals Holding Corp. Analysts have issued a net profit forecast 2026. The average Tonix Pharmaceuticals Holding Corp. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -14.57 | -10.37 |
| 91.75% | 28.83% | |
| P/E | negative | |
| EV/Sales | negative |
7 Analysts have issued a Tonix Pharmaceuticals Holding Corp. forecast for earnings per share. The average Tonix Pharmaceuticals Holding Corp. EPS is
This results in the following potential growth metrics and future valuations:
Tonix Pharmaceuticals Holding Corp....
Current Tonix Pharmaceuticals Holding Corp. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Raymond James |
Locked
➜
Locked
|
Locked | Jun 25 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | May 04 2026 |
| Noble Capital Markets |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Raymond James:
Locked
➜
Locked
|
Jun 25 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
May 04 2026 |
|
Locked
Noble Capital Markets:
Locked
➜
Locked
|
Mar 20 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
